What is Carboplatin?
Category: Prescription Drugs
See also: Docetaxel-carboplatin-trastuzumab-pertuzumab Docetaxel-carboplatin-trastuzumab (TCH) Gemcitabine-carboplatin ICE regimen Paclitaxel-trastuzumab-carboplatin
Carboplatin is chemotherapy agent often used to treat ovarian cancer. It may also be used to treat a variety of other cancers including lung, head and neck, endometrial, esophageal, bladder, breast, cervical, central nervous system tumors, and germ cell tumors.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Ovarian cancer | 291 | 9 | |
| Endometrial cancer | 30 | 14 | |
| Lung cancer | 8 | 2 | |
| Bladder cancer | 2 | 0 | |
| Breast cancer | 2 | 1 | |
| Testicular cancer | 2 | 2 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 5 | |
| Moderate | 5 | |
| Mild | 14 | |
| None | 6 |
Duration
Stopped taking Carboplatin
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 2 | |
| 1 - 6 months | 14 | |
| 6 months - 1 year | 4 | |
| 1 - 2 years | 1 |
What people switch to and from
Patients started taking Carboplatin after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Tamoxifen (Tamoxol) | 1 |
Patients stopped taking Carboplatin and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Bevacizumab (Avastin) | 2 | |
| Eribulin (Halaven) | 1 | |
| Lenvatinib (Lenvima) | 1 | |
| Nivolumab (Opdivo) | 1 | |
| Palbociclib (Ibrance) | 1 |
Last updated: